THURSDAY, Sept. 1, 2022 (HealthDay News) — The U.S. Drug Enforcement Administration (DEA) is warning the general public that colorfully dyed fentanyl dubbed “rainbow fentanyl” is easily available across the USA.
Rainbow fentanyl fentanyl pills and powder which come in a number of bright colors, shapes, and sizes is really a deliberate effort by drug traffickers to operate a vehicle addiction amongst kids and adults, said DEA administrator Anne Milgram.
The women and men of the DEA are relentlessly attempting to stop the trafficking of rainbow fentanyl and defeat the Mexican drug cartels which are responsible for almost all the fentanyl that’s being trafficked in the usa, Milgram added within an agency news release.
The DEA along with other police seized colorful fentanyl and fentanyl pills in 18 states in August. The confiscated drugs include pills, powders and blocks that resemble sidewalk chalk.
Despite assertions that some colors may be stronger than others, DEA laboratory testing has found no evidence to aid these claims. Still, fentanyl is incredibly dangerous, regardless of the colour, shape or size, the DEA said.
A synthetic opioid, fentanyl is 100 times stronger than morphine and 50 times stronger than heroin. A lethal dose of fentanyl is regarded as less than 2 milligrams, or around 10 to 15 grains of table salt. It really is impossible to find out just how much fentanyl is targeted in a pill or powder without conducting laboratory testing, based on the DEA.
Moreover, fentanyl remains probably the most lethal drug threat to america. The U.S. Centers for Disease Control and Prevention estimates that 107,622 Americans overdosed and died in 2021, with synthetic opioids like fentanyl the reason for 66% of these deaths. Drug poisoning may be the leading reason behind death for Americans between your ages of 18 and 45.
In the event that you encounter any type of fentanyl, avoid handling it and call 911 immediately, the DEA advised.
The DEAs Fentanyl Awareness page lists additional community and parental resources.
SOURCE: U.S. Drug Enforcement Administration, news release, Aug. 30, 2022